West Pharmaceutical Services Inc. Stock
We can see a decrease in the price for West Pharmaceutical Services Inc.. Compared to yesterday it has lost -€4.200 (-1.290%).
With 6 Buy predictions and not the single Sell prediction the community is currently very high on West Pharmaceutical Services Inc..
As a result the target price of 369 € shows a slightly positive potential of 12.81% compared to the current price of 327.1 € for West Pharmaceutical Services Inc..
Pros and Cons of West Pharmaceutical Services Inc. in the next few years
Pros
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of West Pharmaceutical Services Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| West Pharmaceutical Services Inc. | -1.290% | -2.880% | -7.547% | 1.869% | 1.900% | 21.689% | - |
| Neogen Corp. | 0.830% | 4.310% | 7.080% | -20.395% | -33.880% | -68.158% | -54.682% |
| Bio-Rad Labs Inc. A | 0.070% | 3.856% | -0.220% | -22.551% | -7.357% | -44.033% | - |
| Merit Medical Systems | -1.320% | 0.000% | 11.194% | -3.247% | 9.559% | 52.664% | 49.538% |
Comments
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at KeyCorp from $440.00 to $470.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $536.00 price target on the stock, up previously from $323.00.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for WST provided by MarketBeat